Table 1.
Gene polymorphisms affecting lead toxico-kinetics and toxico-dynamics.
Table 2.
Baseline Characteristics of CHD cases and non-cases, Normative Aging Study (n = 589).
Table 3.
Adjusted estimatesa of CHD per 2-fold increase in patella lead levels, stratified by different gene polymorphisms.
Table 4.
Adjusted effect estimatesa of patella lead, genetic score and interaction between patella lead and genetic risk score.